POINT BIOPHARMA Trademark

Trademark Overview

On Tuesday, August 4, 2020, a trademark application was filed for POINT BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the POINT BIOPHARMA trademark a serial number of 90093341. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, December 11, 2023. This trademark is owned by Point Biopharma Corp.. The POINT BIOPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
point biopharma

General Information

Serial Number90093341
Word MarkPOINT BIOPHARMA
Filing DateTuesday, August 4, 2020
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, December 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of the all-capitalized word "POINT" wherein the "P" and "O" are intersecting so the two interior circles are connected, and wherein the thinner, all-capitalized word "BIOPHARMA" sits directly underneath and to the right of the stem of the "P".
Goods and ServicesPharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Pseudo MarkPOINT BIO PHARMA
Disclaimer with Predetermined Text"BIOPHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 3, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePoint Biopharma Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M4T2S3
CA

Trademark Events

Event DateEvent Description
Tuesday, March 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 12, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, March 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 11, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 11, 2023LETTER OF SUSPENSION E-MAILED
Monday, December 11, 2023SUSPENSION LETTER WRITTEN
Tuesday, June 13, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, June 13, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, June 13, 2023SUSPENSION LETTER WRITTEN
Tuesday, December 13, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, December 13, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, December 13, 2022SUSPENSION LETTER WRITTEN
Monday, December 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 12, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, December 12, 2022ASSIGNED TO LIE
Monday, December 5, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, June 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 6, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, June 6, 2022INQUIRY TO SUSPENSION E-MAILED
Monday, June 6, 2022SUSPENSION INQUIRY WRITTEN
Friday, June 3, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, November 1, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, November 1, 2021LETTER OF SUSPENSION E-MAILED
Monday, November 1, 2021SUSPENSION LETTER WRITTEN
Monday, November 1, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 28, 2021ASSIGNED TO LIE
Friday, October 22, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, August 19, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 19, 2021INQUIRY TO SUSPENSION E-MAILED
Thursday, August 19, 2021SUSPENSION INQUIRY WRITTEN
Wednesday, August 18, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, August 11, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 11, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 24, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, November 24, 2020LETTER OF SUSPENSION E-MAILED
Tuesday, November 24, 2020SUSPENSION LETTER WRITTEN
Tuesday, November 24, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, November 24, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 24, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, November 24, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 24, 2020ASSIGNED TO EXAMINER
Friday, September 4, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, September 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 7, 2020NEW APPLICATION ENTERED

Related Keywords

biopharma point pharmaceutical delivery treatment preparations diagnosis agents drug consisting wide pharmaceuticals